The gastric-derived pentadecapeptide at the centre of tissue-repair research.
BPC-157 is the most-discussed peptide in recovery research, and also one of the most misunderstood. Here's what it actually is and what the published literature examines.
BPC-157 is a synthetic pentadecapeptide — a chain of fifteen amino acids. The sequence is derived from a fragment of "body protection compound," a protein identified in human gastric juice. It does not exist in this isolated form in nature; it's a stable synthetic sequence based on a naturally occurring one.
Most peptides degrade quickly in acidic conditions. BPC-157's origin in gastric juice is directly relevant to its stability profile, and it's part of why the compound appears so consistently across published research rather than being limited to narrow experimental conditions.
A significant portion of BPC-157 literature concerns angiogenesis — the formation of new blood vessels. This matters in repair research because new vasculature delivers the oxygen and nutrients that tissue reconstruction requires.
Research has examined BPC-157 in connective-tissue repair models. Tendon and ligament tissue is poorly vascularised, which is precisely why the angiogenesis angle draws attention in this context.
Given its gastric origin, considerable research has focused on gut-lining integrity and the gut-brain axis.
BPC-157 is frequently researched with TB-500, which is studied for cell migration rather than localized repair — complementary mechanisms. Read the full comparison →
All of the above is research context from laboratory models. BPC-157 is supplied for research use only and is not a treatment.
BPC-157 is among the most counterfeited compounds in this market precisely because it's the most in demand. Insist on a batch-specific third-party COA with HPLC purity and mass-spec identity — here's how to read one.
View BPC-157 research compound →